TB-500 10mg: Healing & Recovery Research Peptide

TB-500 is a synthetic research peptide designed to replicate the active regenerative region of the naturally occurring protein Thymosin Beta-4 (Tβ4). This peptide fragment is widely studied for its potential role in cell migration, tissue repair, angiogenesis, and inflammatory modulation within controlled research environments.

Its small size and enhanced stability make TB-500 a preferred investigative form of the Tβ4 pathway in experimental models.

Scientific Background

Thymosin Beta-4 is a 43-amino-acid peptide found throughout mammalian tissues, with high concentrations in platelets, skin, muscle, and the central nervous system. TB-500 is based on the LKKTET amino-acid sequence — the portion of Tβ4 most strongly associated with:

• Actin regulation
• Cellular motility
• Tissue regeneration
• Blood vessel formation

By focusing on this functional region, TB-500 allows researchers to explore Tβ4-linked biological pathways with improved stability and simplified manufacturing.

Research Areas of Interest

All information below is intended strictly for scientific, laboratory, and in-vitro research discussion only.

1. Tissue Repair & Regeneration

TB-500 is evaluated in preclinical models for its potential to support:

• Cellular migration to injury sites
• Fibroblast activation
• Tissue remodeling and repair
• Accelerated wound closure

2. Angiogenesis

The Tβ4/TB-500 pathway is known to promote:

• Endothelial cell movement
• Capillary formation
• Blood-vessel growth in damaged tissue

3. Anti-Inflammatory Properties

Investigational studies highlight possible reductions in:

• Pro-inflammatory cytokines
• Oxidative stress
• Fibrotic tissue development

4. Musculoskeletal & Soft-Tissue Models

TB-500 is widely researched in models focusing on:

• Muscle regeneration
• Tendon and ligament recovery
• Joint mobility
• Overall soft-tissue adaptation

5. Cardiac Research (Preclinical Only)

Experimental findings suggest the Tβ4 pathway may influence:

• Cardiac progenitor cell activation
• Post-injury tissue repair
• Improved structural integrity following ischemic damage

These findings are entirely preclinical and are not validated or approved for human therapeutic use.

Molecular Profile

• Peptide: TB-500 (Thymosin Beta-4 Fragment)
• Sequence: Ac-LKKTET-NH₂
• Molecular Weight: ~ 800 Da
• Form: Lyophilized powder
• Purity: ≥ 98% (HPLC tested)

Storage & Stability

• Store lyophilized peptide at –20°C in a dry environment
• Reconstituted solutions should be used immediately or stored according to laboratory protocol
• Avoid repeated freeze-thaw cycles

   In preclinical and early experimental research, the Thymosin Beta-4 pathway (and TB-500 as its synthetic analogue) has shown potential benefits in heart repair.
However, this is NOT clinically approved, and all findings are from animal studies, cell models, or early-phase research, not established human medicine.

Each 10ml vial is formulated with 10mg of highly purified (>99%) lyophilized TB-500, produced in sterile environments that meet research-grade standards. Prime Peptides validates every batch through third-party laboratory testing to ensure exact molecular composition, stable peptide structure, and consistent results suitable for a wide range of experimental designs.